CVS Health Corporati

CVS
Delayed Nyse - 07/19 10:00:48 pm
55.94USD
-0.99%
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 2018 2019 (e)
Sales 194 579 252 415
EBITDA 12 734 17 456
Operating profit (EBIT) 10 255 14 763
Pre-Tax Profit (EBT) 1 406 8 920
Net income -594 6 571
P/E ratio -115x 11,1x
EPS ( $ ) -0,57 5,06
Dividend per Share ( $ ) 2,00 1,99
Yield 3,05% 3,55%
Reference price ( $ ) 65,520 55,940
Announcement Date 02/20/2019
11:55am
-
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 2018 2019 (e)
Debt 66 848 63 385
Finance - -
Operating income (EBITDA) 12 734 17 456
Leverage
(Debt/EBITDA)
5,25x 3,63x
Capital Expenditure 2 037 2 522
Book Value Per Share (BVPS) ( $ ) 55,8 53,6
Cash Flow per Share ( $ ) 8,49 8,02
Announcement Date 02/20/2019
11:55am
-
Balance Sheet Analysis
Financial Ratios
Size 2019e 2020e
Capitalization 72 671 M $ -
Entreprise Value (EV) 136 056 M $ 129 549 M $
Valuation 2019e 2020e
P/E ratio (Price / EPS) 11,1x 9,58x
Capitalization / Revenue 0,29x 0,28x
EV / Revenue 0,54x 0,53x
EV / EBITDA 7,79x 7,46x
Yield (DPS / Price) 3,55% 3,56%
Price to book (Price / BVPS) 1,04x 0,96x
Profitability 2019e 2020e
Operating Margin (EBIT / Sales) 5,85% 5,98%
Operating Leverage (Delta EBIT / Delta Sales) 1,48x 2,28x
Net Margin (Net Profit / Revenue) 2,60% 2,96%
ROA (Net Profit / Asset) 4,30% 4,88%
ROE (Net Profit / Equities) 13,5% 14,5%
Rate of Dividend 39,3% 34,1%
Balance Sheet Analysis 2019e 2020e
CAPEX / Sales   1,00% 1,00%
Cash Flow / Sales 4,13% 4,44%
Capital Intensity (Assets / Sales) 0,61x 0,61x
Financial Leverage (Net Debt / EBITDA) 3,63x 3,12x
Price Earning Ratio
BNA & Dividende